Molecular Geneticist in Oncology

Organization
Tempus
Job Location
600 W Chicago Ave
Chicago, IL 60654
Job Description

Passionate about making a difference in the world of cancer genomics?

With the advent of genomic sequencing, we can finally decode and process our genetic makeup. We now have more data than ever before but providers don't have the infrastructure or expertise to make sense of this data. We're on a mission to connect an entire ecosystem to redefine how genomic data is used in clinical settings.

We are seeking a highly motivated and capable Molecular Geneticist with experience in cancer genomic clinical testing. The position requires experience with interpreting and reporting data from next generation sequencing based tests. Top candidates will also have strong communication skill and the ability to explain complex genetic testing results to a broad audience.

Duties and Responsibilities:

  • Assist in variant interpretation and reporting.
  • Advise on development of variant classification systems and guidelines for reporting.
  • Work in interdisciplinary groups of scientists, engineers, and product developers to translate genetic sequencing results into clinically actionable insights for our clients.
  • Contribute to building the Tempus knowledge databases.
  • Produce high quality and detailed documentation for all projects.

 

Required Experience:

  • Board eligible or board certified through the American Board of Medical Genetics and Genomics or American Board of Genetic Counseling
  • 1-2 years of previous job-related experience working with next-generation sequencing data.
  • Experience in oncology.
  • Ideal candidates will possess:
  • Familiarity with reporting guidelines for both somatic and germline genetic testing.
  • Self-driven and works well in interdisciplinary teams
  • Experience with communicating insights and presenting concepts to a diverse audience
About Our Organization

Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and analyze molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data. For more information, visit tempus.com

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.